Professor Marianne van den Bree is a researcher in psychiatric genetics and genetic epidemiology focusing on understanding how genetic and environmental factors influence mental health, neurodevelopment, and wellbeing across the lifespan. As Professor of Psychological Medicine at Cardiff University, she leads interdisciplinary research integrating genetics, psychology, epidemiology, neuroscience, and clinical science to investigate the developmental consequences of rare genomic variation.
Her research focuses on copy number variants (CNVs), rare genetic alterations associated with increased risk of neurodevelopmental and psychiatric disorders. Through large-scale longitudinal studies, she has examined how these variants influence cognition, behaviour, emotional wellbeing, education, and physical health from childhood through adulthood. Her work has contributed to understanding conditions including autism spectrum disorder, schizophrenia, intellectual disability, and ADHD.
She is founder and director of the Cardiff ECHO programme, which studies individuals with rare genomic variants using genetic, clinical, psychological, neuroimaging, cellular, and pharmacological approaches. She also leads research on lifespan multimorbidity, investigating the shared causes of co-occurring mental and physical health conditions. Her work has informed clinical practice, genetic counselling, and support services, helping translate genetic discoveries into improved health outcomes.
Professor Marianne van den Bree is a researcher in psychiatric genetics and genetic epidemiology focusing on understanding how genetic and environmental factors influence mental health, neurodevelopment, and wellbeing across the lifespan. As Professor of Psychological Medicine at Cardiff University, she leads interdisciplinary research integrating genetics, psychology, epidemiology, neuroscience, and clinical science to investigate the developmental consequences of rare genomic variation.
Her research focuses on copy number variants (CNVs), rare genetic alterations associated with increased risk of neurodevelopmental and psychiatric disorders. Through large-scale longitudinal studies, she has examined how these variants influence cognition, behaviour, emotional wellbeing, education, and physical health from childhood through adulthood. Her work has contributed to understanding conditions including autism spectrum disorder, schizophrenia, intellectual disability, and ADHD.
She is founder and director of the Cardiff ECHO programme, which studies individuals with rare genomic variants using genetic, clinical, psychological, neuroimaging, cellular, and pharmacological approaches. She also leads research on lifespan multimorbidity, investigating the shared causes of co-occurring mental and physical health conditions. Her work has informed clinical practice, genetic counselling, and support services, helping translate genetic discoveries into improved health outcomes.